Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYale University
About this trial
This study is stage 2, round 3 of a larger study which refines and optimizes the EMBED clinical decision support (CDS) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder. See NCT03658642
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Emergency department patient
18 years of age or older
Moderate to severe opioid use disorder
Disqualifiers
Under 18 years of age
Pregnant
Currently receiving medication for opioid use disorder
Trial design
Design model
Sequential
Treatments tested in this trial
Refined EMBED CDS
Other interventionRefined EMBED CDS
Provider alert that nurse completed COWS
Other interventionProvider alert that nurse completed COWS
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Refined EMBED CDSActive comparator 2 interventions
Group B: Refined EMBED plus provider alert the nurse completed COWSExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Proportion of encounters with Buprenorphine initiation in the ED
Proportion of eligible encounters with buprenorphine administered in the Emergency Department (ED) and/or prescribed buprenorphine on discharge from the ED. Obtained from EHR data.
Time frame
Trial round start to end up to 3 monthsSecondary outcomes
1
Proportion of eligible encounters with CDS engagement
Proportion of eligible encounters in which any portion of the EMBED workflow was documented or completed.
Time frame
Trial round start to end up to 3 months2
Proportion of encounters in which buprenorphine was ordered through EMBED vs. externally
Proportion of eligible encounters in which buprenorphine order is placed through EMBED (i.e., using EMBED order set).
Time frame
Trial round start to end up to 3 months3
Time spent on EMBED
Time (in seconds) spent on EMBED overall and by component.
Time frame
Trial round start to end up to 3 months4
Task Completion: Proportion of encounters with OUD diagnosis was recorded
Proportion of encounters where EMBED was opened in which the OUD diagnosis was recorded.
Time frame
Trial round start to end up to 3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Yale University
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov